SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-006758
Filing Date
2019-08-01
Accepted
2019-08-01 11:59:16
Documents
68
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q adap-20190630x10q.htm   iXBRL 10-Q 1841387
2 EX-10.1 adap-20190630ex10114cee6.htm EX-10.1 588977
3 EX-31.1 adap-20190630ex3117d44f4.htm EX-31.1 11042
4 EX-31.2 adap-20190630ex312d4d379.htm EX-31.2 11840
5 EX-32.1 adap-20190630ex321083474.htm EX-32.1 6824
6 EX-32.2 adap-20190630ex322172d5a.htm EX-32.2 6839
  Complete submission text file 0001558370-19-006758.txt   6358446

Data Files

Seq Description Document Type Size
7 EX-101.SCH adap-20190630.xsd EX-101.SCH 37412
8 EX-101.CAL adap-20190630_cal.xml EX-101.CAL 57378
9 EX-101.DEF adap-20190630_def.xml EX-101.DEF 73953
10 EX-101.LAB adap-20190630_lab.xml EX-101.LAB 315574
11 EX-101.PRE adap-20190630_pre.xml EX-101.PRE 222972
12 EXTRACTED XBRL INSTANCE DOCUMENT adap-20190630x10q_htm.xml XML 903086
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37368 | Film No.: 19991726
SIC: 2836 Biological Products, (No Diagnostic Substances)